Table 4 median values (interquartile ranges) of medication costs (in Euros, €) in the first year after baseline
Adalimumab (n = 267)Etanercept (n = 289)Infliximab (n = 151)p Value
Anti-TNFα€13 871 (12 957–13 872)€13 938 (12 193–13 938)€14 220 (11 096–16 997)<0.001
DMARDs€51 (17–69)€41 (0–84)€41 (14–68)0.453
Corticosteroids€0 (0–7.7)€0 (0–20)€0 (0–17)0.002
NSAIDs€96 (0–176)€47 (0–176)€87 (0–211)0.336
Total€13 944 (13 239−14 143)€13 985 (12 323–14 279)€14 460 (11 707–17 326)<0.008
  • DMARD, disease-modifying antirheumatic drug; NSAID, non-steroidal anti-inflammatory drug; TNF, tumour necrosis factor.